p value | ||||
---|---|---|---|---|
Factor | t-IPSS+10 | o-IPSS+5 | i-IPSS+5 | |
Age | <66.17 vs >66.17 | 0.838 | 0.959 | 0.253 |
Prostate volume | <36.7 ml vs >36.7 ml | 0.681 | 0.457 | 0.750 |
Risk group | intermediate vs high | 0.820 | 0.540 | 0.318 |
Initial PSA | <11.84 vs >11.84 | 1.000 | 0.609 | 0.124 |
Baseline t-IPSS | <7.67 vs >7.67 | 0.217 | 0.400 | 0.253 |
ADT | yes vs no | 1.000 | 0.505 | 0.472 |
Brachytherapy technique | LDR-ISBT vs HDR-ISBT | 0.066 | 0.193 | 0.010* |
D50 % of urethra | <95.65 Gy vs >95.65 Gy | 0.024* | 0.101 | 0.031* |
D50 % of base of urethra | <95.70 Gy vs >95.70 Gy | 0.152 | 0.397 | 0.031* |
V90 of urethra | <85.32 % vs >85.32 % | 0.152 | 0.397 | 0.031* |
V90 of base of urethra | <75.01 % vs >75.01 % | 0.152 | 0.397 | 0.031* |
V100 of urethra | <17.05 % vs >17.05 % | 0.217 | 0.535 | 0.005* |